NYSE : COR
Cencora, Inc. — Financial statements
Healthcare · Medical Distribution · United States
Last price 330.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 63.13B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cencora, Inc. (COR) reported revenue of 332.77B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 332.77B | 321.33B | 293.96B | 262.17B | 238.59B | 213.99B |
| Cost of Revenue | 319.59B | 310.09B | 284.22B | 253.45B | 230.29B | 207.21B |
| Gross Profit | 13.18B | 11.24B | 9.74B | 8.72B | 8.29B | 6.77B |
| Selling, General & Admin | 7.65B | 6.49B | 5.66B | 5.31B | 4.85B | 3.59B |
| Amortization of Goodwill & Intangibles | 489.09M | 556.93M | 663.47M | 553.56M | 307.30M | 178.35M |
| Other Operating Expenses | -2.16M | |||||
| Operating Expenses | 8.69B | 7.54B | 6.75B | 6.27B | 5.54B | 4.10B |
| Operating Income | 4.49B | 3.70B | 2.99B | 2.45B | 2.75B | 2.68B |
| Interest Expense | -511.58M | -419.75M | -248.68M | -228.93M | -210.67M | -174.07M |
| Interest & Investment Income | 80.18M | 128.21M | 91.69M | |||
| Currency Exchange Gain (Loss) | -21.60M | -5.90M | -1.20M | -9.00M | -11.90M | |
| Other Non Operating Income (Expenses) | -34.35M | -51.34M | 3.12M | 17.13M | -21.81M | -22.98M |
| EBT Excluding Unusual Items | 4.00B | 3.35B | 2.83B | 2.23B | 2.51B | 2.48B |
| Merger & Restructuring Charges | -662.63M | -520.47M | -336.63M | -369.57M | -183.06M | -199.29M |
| Impairment of Goodwill | -889.55M | -723.88M | -418.00M | -75.94M | -6.37M | |
| Gain (Loss) on Sale of Investments | 1.07B | 14.06M | -16.20M | 242.00K | 4.83M | 64.72M |
| Gain (Loss) on Sale of Assets | -22.45M | -35.54M | 40.66M | 56.23M | ||
| Asset Writedown | -83.83M | -4.95M | -11.32M | |||
| Legal Settlements | 186.07M | 175.70M | -56.17M | 263.79M | -121.39M | -103.83M |
| Pretax Income | 3.61B | 2.26B | 2.00B | 2.16B | 2.18B | 2.22B |
| Income Tax Expense | 967.31M | 690.52M | 484.70M | 428.26M | 516.52M | 677.25M |
| Earnings From Continuing Operations | 2.64B | 1.57B | 1.52B | 1.73B | 1.67B | 1.54B |
| Minority Interest in Earnings | -14.46M | -13.64M | -10.15M | 12.72M | 32.28M | -4.68M |
| Net Income | 2.62B | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B |
| Net Income to Common | 2.62B | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B |
| Shares Outstanding (Basic) | 193.95M | 193.82M | 198.50M | 202.51M | 208.47M | 205.92M |
| Shares Outstanding (Diluted) | 195.00M | 195.21M | 200.28M | 204.59M | 211.21M | 208.47M |
| EPS (Basic) | 13.53 | 8.02 | 7.60 | 8.62 | 8.15 | 7.48 |
| EPS (Diluted) | 13.46 | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 |
| Free Cash Flow | 4.06B | 3.21B | 3.00B | 3.45B | 2.21B | 2.23B |
| Free Cash Flow Per Share | 20.82 | 16.43 | 14.97 | 16.88 | 10.45 | 10.69 |
| Dividend Per Share | 2.35 | 2.20 | 2.04 | 1.94 | 1.84 | 1.76 |
| Gross Margin | 3.96% | 3.50% | 3.31% | 3.33% | 3.48% | 3.17% |
| Operating Margin | 1.35% | 1.15% | 1.02% | 0.93% | 1.15% | 1.25% |
| Profit Margin | 0.79% | 0.48% | 0.51% | 0.67% | 0.71% | 0.72% |
| Free Cash Flow Margin | 1.22% | 1.00% | 1.02% | 1.32% | 0.92% | 1.04% |
| EBITDA | 5.55B | 4.76B | 4.10B | 3.42B | 3.45B | 3.18B |
| EBITDA Margin | 1.67% | 1.48% | 1.39% | 1.30% | 1.45% | 1.49% |
| D&A For EBITDA | 1.05B | 1.06B | 1.11B | 972.39M | 697.94M | 505.06M |
| EBIT | 4.49B | 3.70B | 2.99B | 2.45B | 2.75B | 2.68B |
| EBIT Margin | 1.35% | 1.15% | 1.02% | 0.93% | 1.15% | 1.25% |
| Effective Tax Rate | 26.82% | 30.58% | 24.19% | 19.82% | 23.66% | 30.48% |
Balance sheet
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.82B | 4.36B | 3.13B | 2.59B | 3.39B | 2.55B |
| Cash & Short-Term Investments | 2.82B | 4.36B | 3.13B | 2.59B | 3.39B | 2.55B |
| Accounts Receivable | 25.45B | 25.23B | 23.87B | 20.91B | 18.45B | 18.17B |
| Other Receivables | 77.12M | 172.57M | 221.88M | |||
| Receivables | 25.45B | 25.23B | 23.87B | 20.99B | 18.63B | 18.39B |
| Inventory | 21.03B | 20.49B | 19.00B | 17.45B | 15.56B | 15.37B |
| Prepaid Expenses | 586.38M | 500.93M | 440.05M | 351.23M | 342.89M | 390.61M |
| Restricted Cash | 49.67M | 38.41M | 98.60M | 97.72M | 144.98M | 462.99M |
| Other Current Assets | 5.41B | 1.63B | 1.18B | 1.31B | 1.53B | 1.64B |
| Total Current Assets | 55.34B | 52.24B | 47.72B | 42.80B | 39.59B | 38.80B |
| Property, Plant & Equipment | 2.84B | 4.09B | 3.32B | 3.15B | 3.08B | 3.23B |
| Goodwill | 16.52B | 13.68B | 9.32B | 9.57B | 8.50B | 9.03B |
| Other Intangible Assets | 5.93B | 3.77B | 4.00B | 4.43B | 4.33B | 5.26B |
| Long-Term Deferred Tax Assets | 179.42M | 208.81M | 246.35M | 200.67M | 237.57M | 290.79M |
| Other Long-Term Assets | 3.01B | 2.60B | 2.50B | 2.40B | 816.69M | 726.81M |
| Total Assets | 83.81B | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B |
| Accounts Payable | 54.70B | 54.72B | 50.94B | 45.84B | 40.19B | 38.01B |
| Accrued Expenses | 2.17B | 2.31B | 2.55B | 2.17B | 2.06B | 2.68B |
| Short-Term Debt | 105.60M | 1.42M | 286.00K | 68.02M | ||
| Current Portion of Long-Term Debt | 173.55M | 116.36M | 576.04M | 573.33M | 1.07B | 300.21M |
| Current Portion of Leases | 432.53M | 253.77M | 204.77M | 182.46M | 158.18M | 175.35M |
| Other Current Liabilities | 1.61B | 416.00M | 192.07M | |||
| Total Current Liabilities | 59.20B | 57.82B | 54.28B | 48.83B | 43.48B | 41.36B |
| Long-Term Debt | 11.44B | 7.54B | 3.81B | 4.15B | 4.63B | 6.38B |
| Long-Term Leases | 2.31B | 1.42B | 1.03B | 924.25M | 864.29M | 946.15M |
| Long-Term Deferred Tax Liabilities | 1.79B | 1.62B | 1.64B | 1.66B | 1.62B | 1.69B |
| Other Long-Term Liabilities | 5.83B | 6.44B | 5.55B | 6.33B | 5.89B | 6.38B |
| Total Liabilities | 80.57B | 74.84B | 66.31B | 61.89B | 56.49B | 56.75B |
| Common Stock | 2.98M | 2.97M | 2.96M | 2.95M | 2.93M | 2.91M |
| Additional Paid-In Capital | 6.34B | 6.20B | 6.03B | 5.84B | 5.66B | 5.47B |
| Retained Earnings | 9.14B | 6.53B | 5.42B | 4.32B | 2.98B | 1.67B |
| Treasury Stock | -11.45B | -10.33B | -9.82B | -8.25B | -7.02B | -6.47B |
| Comprehensive Income & Other | -979.74M | -901.38M | -989.12M | -1.40B | -1.83B | -445.44M |
| Total Common Equity | 3.05B | 1.51B | 645.94M | 522.00M | -211.56M | 223.35M |
| Minority Interest | 188.13M | 239.07M | 140.80M | 144.28M | 282.83M | 361.06M |
| Shareholders' Equity | 3.24B | 1.75B | 786.74M | 666.29M | 71.27M | 584.41M |
| Total Liabilities & Equity | 83.81B | 76.59B | 67.10B | 62.56B | 56.56B | 57.34B |
| Total Debt | 14.46B | 9.33B | 5.62B | 5.89B | 6.73B | 7.81B |
| Net Cash (Debt) | -11.65B | -4.98B | -2.49B | -3.30B | -3.34B | -5.26B |
| Net Cash Per Share | -59.73 | -25.49 | -12.43 | -16.14 | -15.80 | -25.22 |
| Filing Date Shares Outstanding | 190.83M | 193.99M | 193.28M | 200.71M | 205.67M | 208.13M |
| Total Common Shares Outstanding | 190.83M | 193.94M | 194.94M | 200.81M | 206.20M | 208.09M |
| Working Capital | -3.86B | -5.58B | -6.56B | -6.03B | -3.89B | -2.56B |
| Book Value Per Share | 15.99 | 7.78 | 3.31 | 2.60 | -1.03 | 1.07 |
| Tangible Book Value | -19.40B | -15.94B | -12.67B | -13.48B | -13.05B | -14.06B |
| Tangible Book Value Per Share | -101.64 | -82.21 | -65.01 | -67.15 | -63.28 | -67.59 |
| Land | 125.00M | 117.13M | 116.47M | 122.43M | 129.94M | |
| Buildings | 1.13B | 893.69M | 836.17M | 840.85M | 838.62M | |
| Machinery | 4.48B | 4.20B | 3.79B | 3.42B | 3.11B |
Cash flow statement
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 2.62B | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B |
| Depreciation & Amortization | 1.05B | 1.06B | 1.11B | 972.39M | 697.94M | 505.06M |
| Other Amortization | 13.89M | 10.17M | 7.17M | 8.46M | 11.89M | 9.72M |
| Loss (Gain) From Sale of Assets | -52.02M | 35.54M | -40.66M | -56.23M | ||
| Asset Writedown & Restructuring Costs | 1.09B | 837.38M | 418.00M | 80.88M | 17.70M | |
| Loss (Gain) From Sale of Investments | -1.07B | -26.90M | 16.20M | -242.00K | -4.83M | -64.72M |
| Stock-Based Compensation | 148.73M | 147.96M | 148.00M | 124.62M | 93.40M | 99.59M |
| Provision & Write-off of Bad Debts | 24.64M | 63.31M | 40.83M | 54.39M | 26.05M | 12.10M |
| Other Operating Activities | 128.92M | 159.82M | -65.00M | 172.54M | 294.82M | 179.88M |
| Change in Accounts Receivable | -1.70B | -1.92B | -2.78B | -2.71B | -1.66B | -930.08M |
| Change in Inventory | -1.33B | -1.27B | -1.48B | -2.18B | -665.37M | -1.12B |
| Change in Accounts Payable | 4.39B | 3.69B | 4.97B | 6.10B | 3.32B | 2.05B |
| Change in Income Taxes | -160.81M | -213.72M | -204.52M | -196.15M | -280.77M | 88.43M |
| Change in Other Net Operating Assets | -335.85M | -251.38M | -200.95M | -137.61M | -854.72M | 276.14M |
| Operating Cash Flow | 4.82B | 3.88B | 3.48B | 3.91B | 2.70B | 2.67B |
| Capital Expenditures | -760.85M | -667.98M | -487.17M | -458.36M | -496.32M | -438.22M |
| Sale of Property, Plant & Equipment | 45.82M | |||||
| Cash Acquisitions | -5.07B | -4.10B | -69.77M | -1.41B | -133.81M | -5.56B |
| Divestitures | 25.00M | 272.59M | ||||
| Investment in Securities | -30.93M | -196.24M | -30.43M | -743.27M | -18.49M | -162.62M |
| Other Investing Activities | 49.76M | -17.44M | -30.72M | 9.00M | 7.60M | 22.30M |
| Investing Cash Flow | -5.74B | -4.98B | -618.10M | -2.60B | -368.44M | -6.14B |
| Long-Term Debt Issued | 136.64B | 70.39B | 78.38B | 4.99B | 8.14B | |
| Long-Term Debt Repaid | -133.45B | -70.78B | -79.00B | -5.91B | -5.92B | |
| Net Debt Issued (Repaid) | 3.15B | 3.20B | -385.45M | -623.26M | -923.10M | 2.22B |
| Issuance of Common Stock | 29.13M | 29.13M | 37.84M | 61.15M | 93.91M | 198.75M |
| Repurchase of Common Stock | -1.11B | -513.25M | -1.55B | -1.25B | -521.78M | -105.70M |
| Common Dividends Paid | -468.07M | -437.08M | -416.17M | -398.75M | -391.69M | -366.65M |
| Other Financing Activities | -32.73M | -25.35M | -12.35M | -9.41M | -10.12M | 9.89M |
| Financing Cash Flow | 1.57B | 2.25B | -2.33B | -2.22B | -1.75B | 1.95B |
| Foreign Exchange Rate Adjustments | -33.99M | -50.27M | 9.40M | 72.76M | -57.85M | -3.73M |
| Miscellaneous Cash Flow Adjustments | -31.18M | -610.00K | -1.75M | |||
| Net Cash Flow | 589.63M | 1.10B | 544.99M | -840.65M | 523.41M | -1.53B |
| Free Cash Flow | 4.06B | 3.21B | 3.00B | 3.45B | 2.21B | 2.23B |
| Free Cash Flow Margin | 1.22% | 1.00% | 1.02% | 1.32% | 0.92% | 1.04% |
| Free Cash Flow Per Share | 20.82 | 16.43 | 14.97 | 16.88 | 10.45 | 10.69 |
| Levered Free Cash Flow | 2.04B | 3.25B | 3.60B | 3.79B | 3.32B | 1.57B |
| Unlevered Free Cash Flow | 2.35B | 3.50B | 3.75B | 3.92B | 3.43B | 1.66B |
| Cash Interest Paid | 451.60M | 356.50M | 250.10M | 271.30M | 219.80M | 170.90M |
| Cash Income Tax Paid | 542.50M | 571.20M | 603.90M | 463.10M | 244.40M | 93.50M |
| Change in Working Capital | 864.94M | 35.42M | 298.69M | 874.54M | -139.66M | 367.32M |
Ratios
Fiscal year October - September; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 63.13B | 60.59B | 44.12B | 36.15B | 28.05B | 24.82B |
| Enterprise Value | 74.78B | 68.74B | 47.08B | 41.35B | 32.67B | 31.03B |
| Last Close Price | 330.84 | 310.17 | 221.53 | 175.51 | 130.45 | 113.65 |
| PE Ratio | 24.58 | 38.99 | 29.23 | 20.71 | 16.51 | 16.12 |
| Forward PE | 17.12 | 18.36 | 15.53 | 14.46 | 12.01 | 11.51 |
| PS Ratio | 0.19 | 0.19 | 0.15 | 0.14 | 0.12 | 0.12 |
| PB Ratio | 20.69 | 34.68 | 56.08 | 54.25 | 393.53 | 42.47 |
| P/FCF Ratio | 15.55 | 18.89 | 14.72 | 10.47 | 12.71 | 11.14 |
| P/OCF Ratio | 13.10 | 15.64 | 12.66 | 9.24 | 10.38 | 9.31 |
| PEG Ratio | 1.76 | 1.60 | 1.56 | 1.66 | 1.30 | 0.97 |
| EV/Sales Ratio | 0.22 | 0.21 | 0.16 | 0.16 | 0.14 | 0.14 |
| EV/EBITDA Ratio | 13.48 | 14.45 | 11.49 | 12.09 | 9.47 | 9.76 |
| EV/EBIT Ratio | 16.65 | 18.59 | 15.77 | 16.90 | 11.87 | 11.60 |
| EV/FCF Ratio | 18.42 | 21.43 | 15.71 | 11.97 | 14.80 | 13.93 |
| Debt / Equity Ratio | 4.46 | 5.34 | 7.15 | 8.85 | 94.36 | 13.36 |
| Debt / EBITDA Ratio | 2.44 | 1.83 | 1.28 | 1.60 | 1.81 | 2.32 |
| Debt / FCF Ratio | 3.56 | 2.91 | 1.88 | 1.71 | 3.05 | 3.50 |
| Net Debt / Equity Ratio | 3.60 | 2.85 | 3.17 | 4.96 | 46.82 | 9.00 |
| Net Debt / EBITDA Ratio | 2.10 | 1.05 | 0.61 | 0.97 | 0.97 | 1.65 |
| Net Debt / FCF Ratio | 2.87 | 1.55 | 0.83 | 0.96 | 1.51 | 2.36 |
| Asset Turnover | 4.22 | 4.47 | 4.53 | 4.40 | 4.19 | 4.21 |
| Inventory Turnover | 15.53 | 15.70 | 15.59 | 15.36 | 14.89 | 14.82 |
| Quick Ratio | 0.48 | 0.51 | 0.50 | 0.48 | 0.51 | 0.51 |
| Current Ratio | 0.94 | 0.90 | 0.88 | 0.88 | 0.91 | 0.94 |
| Return on Equity (ROE) | 96.87% | 123.75% | 209.12% | 469.81% | 508.34% | |
| Return on Assets (ROA) | 3.56% | 3.22% | 2.88% | 2.57% | 3.02% | 3.29% |
| Return on Invested Capital (ROIC) | 20.95% | 51.34% | 62.49% | 53.18% | 45.41% | 22.87% |
| Return on Capital Employed (ROCE) | 18.30% | 19.70% | 23.30% | 17.80% | 21.00% | 16.70% |
| Earnings Yield | 4.07% | 2.56% | 3.42% | 4.83% | 6.06% | 6.20% |
| FCF Yield | 6.43% | 5.29% | 6.79% | 9.55% | 7.87% | 8.98% |
| Dividend Yield | 0.73% | 0.70% | 0.90% | 1.08% | 1.35% | 1.48% |
| Payout Ratio | 17.83% | 28.12% | 27.58% | 22.85% | 23.06% | 23.81% |
| Buyback Yield / Dilution | 0.46% | 2.53% | 2.10% | 3.13% | -1.32% | -1.80% |
| Total Shareholder Return | 1.18% | 3.23% | 3.01% | 4.21% | 0.04% | -0.32% |